Volume 10, Issue 1 (2019, Volume 10, Number 1 2019)
jdc 2019, 10(1): 30-37 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alirezaei P, Memarzadeh Z, Molkara S, Yaghoubi Al S F. Comparison of the efficacy of betamethasone lotion with clotrizone (betamethasone + clotrimazole) lotion in seborrheic dermatitis of face and scalp. jdc 2019; 10 (1) :30-37
URL: http://jdc.tums.ac.ir/article-1-5370-en.html
URL: http://jdc.tums.ac.ir/article-1-5370-en.html
1- Department of Dermatology, Medical School, Hamedan University of Medical Sciences, Hamedan, Iran * Center for Psoriasis Research, Medical School, Hamedan University of Medical Sciences, Hamedan, Iran
2- Department of Dermatology, Mashhad University of Medical Sciences, Mashhad, Iran
3- Department of Dermatology, Medical School, Hamedan University of Medical Sciences, Hamedan, Iran ,mramirrryousefi@gmail.com
2- Department of Dermatology, Mashhad University of Medical Sciences, Mashhad, Iran
3- Department of Dermatology, Medical School, Hamedan University of Medical Sciences, Hamedan, Iran ,
Abstract: (87215 Views)
Background and Aim: Seborrhoic dermatitis is one of the most common diseases in dermatology with a prevalence of about 2%. Many treatments have been used for this disease. This Study aimed to investigate the efficacy of betamethasone lotion compared with clotrizone lotion in patients with seborrheic dermatitis of face and scalp.
Methods: This double blind study was performed on 60 patients with seborrheic dermatitis older than 18 years, who refered to Emam Reza hospital, Mashhad. Patients were divided into two groups: clotrizone (31) and betamethasone group (29 patients). Patients were treated for a month. We evaluated severity of pruritus, erythema and desquamation of the face and scalp.
Results: The average age of patients participating in the study was 33.1 years (18 to 56 years) and 56.7% of patients were male. No significant differences were found in age and gender between the two groups (P> 0.05). Both treatments reduced severity of erythema and desquamation of the face and scalp (P<0.001). Two weeks after treatment, clotrizone had better performance, but there after both lotions had similar effect. Betamethasone reduced pruritus more than clotrizone.
Conclusion: This study showed that both betamethasone and clotrizone were effective. Clotrizone has better impact on the severity of erythema and scaling and betamethasone has better effect on improving the severity of pruritus.
Methods: This double blind study was performed on 60 patients with seborrheic dermatitis older than 18 years, who refered to Emam Reza hospital, Mashhad. Patients were divided into two groups: clotrizone (31) and betamethasone group (29 patients). Patients were treated for a month. We evaluated severity of pruritus, erythema and desquamation of the face and scalp.
Results: The average age of patients participating in the study was 33.1 years (18 to 56 years) and 56.7% of patients were male. No significant differences were found in age and gender between the two groups (P> 0.05). Both treatments reduced severity of erythema and desquamation of the face and scalp (P<0.001). Two weeks after treatment, clotrizone had better performance, but there after both lotions had similar effect. Betamethasone reduced pruritus more than clotrizone.
Conclusion: This study showed that both betamethasone and clotrizone were effective. Clotrizone has better impact on the severity of erythema and scaling and betamethasone has better effect on improving the severity of pruritus.
Type of Study: Research |
Subject:
Special
Received: 2019/06/27 | Accepted: 2019/06/27 | Published: 2019/06/27
Received: 2019/06/27 | Accepted: 2019/06/27 | Published: 2019/06/27
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
